CN103142526A - Dropping pills containing colloidal bismuth pectin - Google Patents
Dropping pills containing colloidal bismuth pectin Download PDFInfo
- Publication number
- CN103142526A CN103142526A CN2013100926509A CN201310092650A CN103142526A CN 103142526 A CN103142526 A CN 103142526A CN 2013100926509 A CN2013100926509 A CN 2013100926509A CN 201310092650 A CN201310092650 A CN 201310092650A CN 103142526 A CN103142526 A CN 103142526A
- Authority
- CN
- China
- Prior art keywords
- drop pill
- colloidal bismmth
- bismmth pectin
- clathrate
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001277 pectin Polymers 0.000 title claims abstract description 44
- 235000010987 pectin Nutrition 0.000 title claims abstract description 44
- 239000001814 pectin Substances 0.000 title claims abstract description 44
- 239000006187 pill Substances 0.000 title claims abstract description 40
- 229910052797 bismuth Inorganic materials 0.000 title abstract description 5
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 title abstract description 5
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims description 15
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 11
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 11
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 10
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 10
- 229940057995 liquid paraffin Drugs 0.000 claims description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 8
- 235000021355 Stearic acid Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 7
- 239000008117 stearic acid Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 5
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 5
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 3
- 239000001828 Gelatine Substances 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 230000003139 buffering effect Effects 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 235000019800 disodium phosphate Nutrition 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims description 2
- -1 polyoxyethylene monostearate Polymers 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 208000007882 Gastritis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010316 high energy milling Methods 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Group | Smooth rounding rate (%) | Dissolve scattered time limit (min) |
Embodiment 1 | 98.64 | 2.1 |
Embodiment 2 | 90.41 | 2.9 |
Embodiment 3 | 91.32 | 2.6 |
Embodiment 4 | 85.46 | 2.8 |
Embodiment 5 | 83.92 | 2.2 |
Embodiment 6 | 86.14 | 2.5 |
Matched group 1 | 80.37 | 5.6 |
Matched group 2 | 77.83 | 6.0 |
Matched group 3 | 74.38 | 5.8 |
Matched group 4 | 76.98 | 5.7 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310092650.9A CN103142526B (en) | 2013-03-21 | 2013-03-21 | Dropping pills containing colloidal bismuth pectin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310092650.9A CN103142526B (en) | 2013-03-21 | 2013-03-21 | Dropping pills containing colloidal bismuth pectin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103142526A true CN103142526A (en) | 2013-06-12 |
CN103142526B CN103142526B (en) | 2014-04-30 |
Family
ID=48541042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310092650.9A Active CN103142526B (en) | 2013-03-21 | 2013-03-21 | Dropping pills containing colloidal bismuth pectin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142526B (en) |
-
2013
- 2013-03-21 CN CN201310092650.9A patent/CN103142526B/en active Active
Non-Patent Citations (1)
Title |
---|
杨楠等: "砷、锑、铋类药物的应用历史和现状", 《化学进展》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103142526B (en) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102463682B1 (en) | Viscosity-reducing excipient compounds for protein formulations | |
CN107098832B (en) | A kind of honokiol derivative and the preparation method and application thereof | |
JPH0535129B2 (en) | ||
CN101468138A (en) | Gel patch for treating insomnia and method for preparing the same | |
CN105250231A (en) | Drug combination containing etoricoxib and preparation method thereof | |
CN102614111A (en) | Glucosamine gel and preparation method thereof | |
CN103142548B (en) | Colloidal bismuth pectin capsule | |
CN103127015B (en) | Alfacalcidol dropping pill and preparation method thereof | |
CN103142526B (en) | Dropping pills containing colloidal bismuth pectin | |
CN106038584A (en) | Colloidal bismuth pectin capsule preparation and preparation method thereof | |
CN103356492A (en) | Tripterine pharmaceutical composition using albumin as pharmaceutical carrier | |
CN102697744B (en) | Allose tablet excipient, medicinal tablet and method for preparing medicinal tablet | |
US11260025B1 (en) | In situ gelling composition as a pH-selective and mucoadhesive sustained release drug delivery system | |
CN103083269B (en) | Dropping pills containing mannose ester and preparation method thereof | |
CN103110636B (en) | Paracetamol and caffeine dropping pill and preparation method thereof | |
CN103110629B (en) | Compound phenol caplets dropping pills and preparation method thereof | |
CN103142523B (en) | Dropping pills containing etoposide | |
CN108136210A (en) | composition containing tannin | |
CN103127021A (en) | Vitamin c dropping pill | |
CN104971070A (en) | Oral nano composition of ticagrelor | |
CN102028836A (en) | Medicine dropping pill used for clearing heat and diminishing swelling and preparation method thereof | |
CN104352556A (en) | Radix sophorae flavescentis total alkaloids dropping pill | |
CN104147436B (en) | A kind of coix seed oil oral administration nanometer grain and preparation method thereof | |
CN103127027B (en) | Polysaccharide sulphate dropping pill | |
CN106619580A (en) | Antipyretic-analgesic externally-used patch prepared from high polymer material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 266103 Qingdao economic and Technological Development Zone, unity Road, No. 3601, Shandong Applicant after: Qingdao Zhengda Haier Pharmaceutical Co.,Ltd. Address before: 266103 Haier Road, Shandong, Qingdao, No. 1 Applicant before: Qingdao Zhengda Haier Pharmaceutical Co.,Ltd. |
|
CB02 | Change of applicant information | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 266103 3601 Tuen Jie Road, Qingdao economic and Technological Development Zone, Shandong Patentee after: CP PHARMACEUTICAL (QINGDAO) Co.,Ltd. Address before: 266103 3601 Tuen Jie Road, Qingdao economic and Technological Development Zone, Shandong Patentee before: Qingdao Zhengda Haier Pharmaceutical Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: No.3601 Tuanjie Road, Qingdao Economic and Technological Development Zone, Shandong Province 266426 Patentee after: Qingdao Guoxin Pharmaceutical Co.,Ltd. Country or region after: China Address before: No. 3601 Tuanjie Road, Qingdao Economic and Technological Development Zone, Shandong Province Patentee before: CP PHARMACEUTICAL (QINGDAO) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |